First Allied Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History

First Allied Advisory Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$2.6M	Sell	9,535 -341	-3%	-$94.1K	0.09%	241
2020 Q2	$2.87M	Buy	9,876 +3,736	+61%	+$1.01M	0.11%	203
2020 Q1	$1.46M	Buy	6,140 +789	+15%	+$181K	0.06%	310
2019 Q4	$1.18M	Buy	5,351 +653	+14%	+$132K	0.04%	424
2019 Q3	$800K	Buy	4,698 +691	+17%	+$122K	0.03%	531
2019 Q2	$735K	Buy	4,007 +755	+23%	+$132K	0.03%	551
2019 Q1	$593K	Sell	3,252 -244	-7%	-$45.1K	0.02%	620
2018 Q4	$572K	Sell	3,496 -600	-15%	-$104K	0.02%	573
2018 Q3	$793K	Buy	4,096 +1,922	+88%	+$342K	0.03%	550
2018 Q2	$372K	Buy	2,174 +204	+10%	+$31.6K	0.01%	792
2018 Q1	$318K	Sell	1,970 -15	-0.8%	-$2.45K	0.01%	842
2017 Q4	$296K	Sell	1,985 -286	-13%	-$42.3K	0.01%	881
2017 Q3	$345K	Sell	2,271 -183	-7%	-$27.5K	0.01%	757
2017 Q2	$315K	Sell	2,454 -169	-6%	-$20.3K	0.01%	803
2017 Q1	$287K	Buy	+2,623	New	+$231K	0.01%	805
2016 Q4	–	Sell	-2,547	Closed	-$222K	–	1171
2016 Q3	$222K	Sell	2,547 -6,393	-72%	-$604K	0.01%	892
2016 Q2	$774K	Sell	8,940 -1,931	-18%	-$167K	0.04%	423
2016 Q1	$872K	Buy	10,871 +8,266	+317%	+$748K	0.05%	393
2015 Q4	$329K	Buy	2,605 +88	+3%	+$10.6K	0.02%	740
2015 Q3	$265K	Sell	2,517 -543	-18%	-$69.8K	0.01%	805
2015 Q2	$379K	Buy	3,060 +509	+20%	+$64.1K	0.02%	731
2015 Q1	$304K	Sell	2,551 -1,169	-31%	-$140K	0.02%	772
2014 Q4	$444K	Buy	+3,720	New	+$419K	0.03%	572

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Allied Advisory Services's VRTX Position: Q3 2020 in Review

First Allied Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 3.5% in Q3 2020, selling an estimated $94.1K and leaving 9,535 shares worth $2.6M. The position accounts for 0.09% of the portfolio, ranked #241.

First Allied Advisory Services first reported a position in VRTX in Q4 2014 and has held it in 23 quarters since. The position peaked at $2.87M in Q2 2020. 951 funds tracked by Wall St. Rank hold VRTX as of Q3 2020.

First Allied Advisory Services held 9,535 shares of Vertex Pharmaceuticals worth $2.6M as of Q3 2020.
First Allied Advisory Services sold 341 Vertex Pharmaceuticals shares in Q3 2020, an estimated $94.1K.
Vertex Pharmaceuticals made up 0.09% of First Allied Advisory Services's portfolio in Q3 2020, its #241 holding.
First Allied Advisory Services first reported a position in Vertex Pharmaceuticals in Q4 2014 and has held it in 23 quarters since.
First Allied Advisory Services's Vertex Pharmaceuticals position peaked at $2.87M in Q2 2020.
951 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.